SCHEMBL21101910

SCHEMBL21101910

CC(=O)Cc1ccc(C(C)(C)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
CYP2C19 P33261 1/20 0.40
GRIA2 P42262 1/20 0.40
PIK3CA P42336 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
RXRA P19793 3/20 0.39
RXRB P28702 3/20 0.39
RXRG P48443 3/20 0.39
CES1 P23141 1/20 0.38
NR1H4 Q96RI1 4/20 0.38
EPHX2 P34913 2/20 0.38
MAOB P27338 1/20 0.38
GRB2 P62993 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ESRRB O95718 1/20 0.37
ESRRG P62508 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
PTPN1 P18031 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265118 0.86 PIK3CA (0.53) POLBPIK3CAHDAC1HDAC8RXRA
SCHEMBL4689867 0.83 NR1H4 (0.51) POLBHDAC8RXRARXRBRXRG
SCHEMBL26382764 0.82 POLB (0.44) POLBCYP2C19GRIA2PIK3CAHDAC1
SCHEMBL2652603 0.81 RXRA (0.56) PIK3CAHDAC1HDAC8RXRARXRB
SCHEMBL8403545 0.80 POLB (0.61) POLBCES1LMNA
SCHEMBL21101918 0.80 TACR1 (0.37) POLBCYP2C19GRIA2RXRARXRB
SCHEMBL9271085 0.78 CNR2 (0.48) POLBCYP2C19MAPTSMN1; SMN2
SCHEMBL21101909 0.78 CYP1A2 (0.50) CYP2C19HDAC1HDAC8MAOBMAPT
SCHEMBL26382771 0.78 POLB (0.49) POLBCYP2C19GRIA2PIK3CAHDAC1
SCHEMBL9266226 0.77 LTA4H (0.56) POLBPIK3CAHDAC1HDAC8EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed